2.43%XLF 15.10 
10.30%QQQQ 31.32 0.63%
The Global Business News Leader | Saturday, 11 Oct 2008
- EQUITY MARKETS
- BONDS AND RATES
- FOREX
- COMMODITIES
- LANGUAGES
- FUNDS
- RETIREMENT
- TAXES
- INSURANCE
- LANGUAGES
- MOVIE
- MUSIC
- TV
- CELEBRITIES
- LANGUAGES
MANNKIND CORPORATION
MNKD (NASDAQ)
$ 2.99 
Change: +0.07 +2.34% | Volume: 682,671
Change: +0.07 +2.34% | Volume: 682,671
Sponsored by 
MANNKIND CORP - Fundamental Profile
Company Information
| Ticker Symbol: | MNKD |
|---|---|
| Exchange: | NASD |
| Contact Info: | 28903 North Avenue Paine Valencia CA 91355 661 775-5300 |
| CEO/President: | Alfred E. Mann |
| Industry: | Medical - Biomedical / Standard Industry Code: 2834 |
| Description: | Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company\'s lead product, the Technosphere Insulin System, consists of the Company\'s dry-powder Technosphere formulation of insulin and the Company\'s MedTone inhaler through which the powder is inhaled into the deep lung. |
Share Information
| Shares Outstanding: | 101,430 (000) | Market Value: | 331,210 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 50.16% | Number of Inst.Shareholders: | 49.20% |
| Last Quarter Sales: | 0.00 ($Mil.) | Last Quarter Net Income: | -79.83 ($Mil.) |
| Last Quarter EPS: | -0.79 | P/E Ratio: | 0 |
| Most Recent Earnings: | -0.79 on 08/11/08 | Earnings Per Share: | -3.23 |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
Most Popular 
MNKD
Companies
IBT
- AIG Units Party, Luxury Resort Conference Upsets Watchdogs
- Ahead of the Bell: Morgan Stanley plunges
- Gold bullion and stocks shine during one of most volatile days
- Harley revs up cooler image with supermodel Miller
- Morgan Stanley shares sink on worries about future
- SEC head asks for reins on credit default swaps
- Fed slashes interest rates, but stocks lose again
- Brad Pitts exclusive photos of Angelina Jolie breastfeeding appears on W Magazine Cover
- W Magazine Angelina Jolie: I bought Maddox his first knife
- Sarah Palin is Princess Dianas and Roosevelts distant cousin
- Angelina Jolie: My Twins Are Totally Sweet
- Ahead of Troopergate Report, NYT Says Official Pressured Indirectly
- Playboy Hugh Hefner New Girlfriends: Karissa and Kristina Shannon, Amy Leigh Andrews
- PHOTO: W Magazine cover shows Angelina Jolie breastfeeding
Top Competitors
| AMGEN |  |
+14.00 | 58.89 |
| GILEAD SCIENCES |  |
-0.20 | 45.75 |
| GENENTECH INC | |
+16.10 | 87.53 |
| CELGENE CP | |
-14.40 | 60.46 |
| BIOGEN IDEC INC | |
-16.30 | 50.50 |
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives